{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:41:58Z","timestamp":1767177718100,"version":"build-2238731810"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T00:00:00Z","timestamp":1288310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0013753","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T15:27:12Z","timestamp":1288366032000},"page":"e13753","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models"],"prefix":"10.1371","volume":"5","author":[{"given":"Mattia C. F.","family":"Prosperi","sequence":"first","affiliation":[]},{"given":"Michal","family":"Rosen-Zvi","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Altmann","sequence":"additional","affiliation":[]},{"given":"Maurizio","family":"Zazzi","sequence":"additional","affiliation":[]},{"given":"Simona","family":"Di Giambenedetto","sequence":"additional","affiliation":[]},{"given":"Rolf","family":"Kaiser","sequence":"additional","affiliation":[]},{"given":"Eugen","family":"Sch\u00fclter","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Struck","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Sloot","sequence":"additional","affiliation":[]},{"given":"David A.","family":"van de Vijver","sequence":"additional","affiliation":[]},{"given":"Anne-Mieke","family":"Vandamme","sequence":"additional","affiliation":[]},{"given":"Anders","family":"S\u00f6nnerborg","sequence":"additional","affiliation":[]},{"name":"for the EuResist and Virolab study groups","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2010,10,29]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.","volume":"304","author":"MA Thompson","year":"2010","journal-title":"JAMA"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1473-3099(09)70136-7","article-title":"Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.","volume":"9","author":"RK Gupta","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/COH.0b013e32832c1898","article-title":"Advances and future directions in HIV surveillance in low- and middle-income countries.","volume":"4","author":"T Diaz","year":"2007","journal-title":"Curr Opin HIV AIDS. 2009 Jul;"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijantimicag.2007.01.003","article-title":"HIV resistance and the developing world.","volume":"29","author":"RK Gupta","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"ref5","first-page":"939","article-title":"Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ.","volume":"86","author":"M Forster","year":"2008"},{"issue":"9534","key":"ref6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.","volume":"5; 368","author":"CF Gilks","year":"2006","journal-title":"Lancet"},{"issue":"17","key":"ref7","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1097\/QAD.0b013e3283121ca9","article-title":"Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.","volume":"22","author":"D Nash","year":"2008","journal-title":"AIDS"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e328011ec53","article-title":"HIV drug resistance surveillance for prioritizing treatment in resource-limited settings.","volume":"21","author":"RP Walensky","year":"2007","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.aids.0000279707.01557.b2","article-title":"Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research.","volume":"4","author":"MA Boyd","year":"2007","journal-title":"AIDS"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0b013e328137709e","article-title":"The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.","volume":"21","author":"D Bishai","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.qai.0000243105.80393.42","article-title":"Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings.","volume":"43","author":"DM Moore","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1473-3099(05)70327-3","article-title":"A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.","volume":"6","author":"R Colebunders","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"1-2","key":"ref13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jviromet.2007.06.019","article-title":"Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings.","volume":"146","author":"K Steegen","year":"2007","journal-title":"J Virol Methods"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-0691.2008.02116.x","article-title":"Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens.","volume":"15","author":"A Marconi","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1054\/drup.2002.0235","article-title":"HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries.","volume":"4","author":"M Petrella","year":"2001","journal-title":"Drug Resist Updat"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/QAI.0b013e31817ed7d7","article-title":"Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.","volume":"48","author":"IA Beck","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/COH.0b013e32801682e2","article-title":"Resistance and viral subtypes: how important are the differences and why do they occur?","volume":"2","author":"BG Brenner","year":"2007","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.6026\/97320630002097","article-title":"SMARThivPack: A complexity free and cost effective \u201cthree tests\u201d combo kit model for improving HIV patients monitoring standards in resource poor settings.","volume":"2","author":"A Yari","year":"2007","journal-title":"Bioinformation"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1097\/00002030-200006160-00001","article-title":"A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.","volume":"14","author":"JD Baxter","year":"2000","journal-title":"AIDS"},{"issue":"9171","key":"ref20","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(98)12291-2","article-title":"Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.","volume":"353","author":"J Durant","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/135965350601100312","article-title":"Three-year clinical outcomes of resistance genotyping and expert advice: extended follow-up of the Argenta trial.","volume":"11","author":"A De Luca","year":"2006","journal-title":"Antivir Ther"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jmv.20069","article-title":"Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.","volume":"73","author":"M Alvarez","year":"2004","journal-title":"J Med Virol"},{"key":"ref23","first-page":"37","article-title":"Interpreting resistance data for HIV-1 therapy management - know the limitations.","volume":"8","author":"K Van Laethem","year":"2006","journal-title":"AIDS Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation.","volume":"42","author":"TF Liu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/135965350400900420","article-title":"Clinically validated genotype analysis: guiding principles and statistical concerns.","volume":"9","author":"F Brun-V\u00e9zinet","year":"2004","journal-title":"Antivir Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/bioinformatics\/btm540","article-title":"Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment.","volume":"24","author":"K Deforche","year":"2008","journal-title":"Bioinformatics"},{"issue":"2","key":"ref27","first-page":"169","article-title":"Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance.","volume":"12","author":"A Altmann","year":"2007"},{"issue":"13","key":"ref28","first-page":"i399","article-title":"Selecting anti-HIV therapies based on a variety of genomic and clinical factors.","volume":"24","author":"M Rosen-Zvi","year":"2008"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"e3470","DOI":"10.1371\/journal.pone.0003470","article-title":"Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy.","volume":"3","author":"A Altmann","year":"2008","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/135965350901400315","article-title":"Investigation of Expert Rule Bases, Logistic Regression and Non-Linear Machine Learning Techniques for Predicting Response to Antiretroviral Treatment.","volume":"14","author":"MCF Prosperi","year":"2009","journal-title":"Antiviral Ther"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/135965350701200112","article-title":"The development of Artificial Neural Networks to predict virological Response to combination HIV therapy.","volume":"12","author":"B Larder","year":"2007","journal-title":"Antivir Ther"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.artmed.2009.05.002","article-title":"A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.","volume":"47","author":"D Wang","year":"2009","journal-title":"Artif Intell Med"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jac\/dkq032","article-title":"Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings.","volume":"65","author":"AD Revell","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1468-1293.2008.00523.x","article-title":"Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response.","volume":"9","author":"A Cozzi-Lepri","year":"2008","journal-title":"HIV Medicine"},{"issue":"1","key":"ref35","first-page":"5","article-title":"Random Forests.","volume":"45","author":"L Breiman","year":"2001"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis.","volume":"27","author":"T Fawcett","year":"2006","journal-title":"Pattern Recognition Letters"},{"key":"ref37","article-title":"Inference for the generalization error.","volume":"12","author":"C Nadeau","year":"2000"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-84858-7","article-title":"The Elements of Statistical Learning.","author":"T Hastie","year":"2009"},{"key":"ref39","article-title":"R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.","volume":"3-900051-07-0","year":"2008","journal-title":"ISBN"},{"key":"ref40","article-title":"Data mining: practical machine learning tools and techniques.","author":"IH Witten","year":"2005"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1086\/597305","article-title":"Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database.","volume":"199","author":"A Altmann","year":"2009","journal-title":"J Infect Dis"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.","volume":"15; 48","author":"KJ Metzner","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ref43","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1086\/428852","article-title":"HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach.","volume":"191","author":"PR Harrigan","year":"2005","journal-title":"J Infect Dis"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/135965350901400217","article-title":"Historical resistance profile helps to predict salvage failure.","volume":"14","author":"M Zaccarelli","year":"2009","journal-title":"Antivir Ther"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"e6079","DOI":"10.1371\/journal.pone.0006079","article-title":"Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.","volume":"4","author":"T Le","year":"2009","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1371\/annotation\/d0254103-21b9-4078-836b-57ba5bd1c26a","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T00:00:00Z","timestamp":1303776000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0013753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T18:13:36Z","timestamp":1711908816000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0013753"}},"subtitle":[],"editor":[{"given":"Art F. Y.","family":"Poon","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2010,10,29]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,10,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0013753","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,29]]}}}